Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID Treatment.

Nicolette FrankDouglas DickinsonGarrison LovettYutao LiuHongfang YuJingwen CaiBo YaoXiaocui JiangStephen Hsu

Published in: Pharmaceutics (2024)

The saline-based novel EC16m mucoadhesive nasal nanoformulations rapidly inactivated human coronavirus with mucociliary safety properties comparable to saline, a solution widely used for nasal applications.

Keyphrases

sars cov
chronic rhinosinusitis
endothelial cells
coronavirus disease
respiratory syndrome coronavirus
induced pluripotent stem cells